Viral latency (kw:KW-1251)
Viral latency is the ability of a virus to remain dormant within the host cell, sometimes establishing lifelong occult infection. Depending on the virus, the trigger of latency is highly variable but the host cell context is always determining. Latency can stop upon viral genome reactivation, often promoted by stress cellular signals.
The viral genome can remain latent either as an episome or integrated in the host chromosome. The latter allows replication of the viral genome during host cell division. Virus latency is generally maintained by a few viral genes that keep the viral genome silent and escape from host immune system.
Eukaryotic viruses like some herpesviridae or retroviridae are able to infect their host lifelong thanks to latency. This gives them an enormous advantage for disseminating in their host population: about 90% of human population would be infected with varicella-zoster virus.
Virus | Family | Genus | Latent replication form | Main site of latency | Ref. |
HHV-1, HHV-2 |
Herpesviridae | Simplexvirus | Circular episome | Dorsal root ganglia | ![]() ![]() |
HHV-3 | Herpesviridae | Varicellovirus | Circular episome | Dorsal root ganglia | ![]() |
HHV-4 | Herpesviridae | Lymphocryptovirus | Circular episome | Memory B-cells | ![]() |
HHV-5 | Herpesviridae | Cytomegalovirus | Circular episome | Myeloid progenitor cells | ![]() |
HHV-6 | Herpesviridae | Roseolovirus | Probable telomeric integration | Monocytes (HHV-6B) | ![]() |
HHV-7 | Herpesviridae | Roseolovirus | Circular episome | CD4+ T-cells | ![]() |
HHV-8 | Herpesviridae | Rhadinovirus | Circular episome | B-cells | ![]() |
HIV-1 | Retroviridae | Lentivirus | Provirus | Memory T-cells | ![]() An integrated overview of HIV-1 latency Debbie S Ruelas, Warner C Greene Cell October 24, 2013; 155: 519-529 |
HTLV-1 | Retroviridae | Deltaretrovirus | Provirus | Memory T-cells | ![]() |
Prokaryotic viruses which display a latent phase are called "temperate", or "lysogenic". The term lysogenic refers to a host phenotype: the bacteria can be spontaneously lysed by the latent phage.
Bacteria such as E. coli and Salmonella contain multiple resident proviruses whose variability in number and type constitutes a major source of diversity between strains . Prokaryotic proviruses usually carry cargo genes encoding traits adaptive to the host, among which are virulence factors found in many bacterial pathogens.
Viruses that have the ability to lie latent within a cell have two options when infecting a cell: they can either enter the latency or the lytic pathway. The decision between lytic and latent pathways is regulated by expression of regulatory proteins part of a genetic switch system, usually repressor(s) as well as proteins controlling the stability of the later. The outcome of the followed pathways depends on the ratio of these key regulators. This ratio may be determined by environmental factors such as the host cell type, its shape, or the nutriment availability.
A well known genetic switch system is the one of bacteriophage lambda which includes at least a repressor of the lytic promoter, a repressor of the latency promotor and two key regulators
.
Bjorn Grinde
J Oral Microbiol 2013; 5
Louis-Charles Fortier, Ognjen Sekulovic
Virulence July 1, 2013; 4: 354-365
Kathryn E Huber, Matthew K Waldor
Nature June 6, 2002; 417: 656-659
Caroline Ranquet, Ariane Toussaint, Hidde de Jong, Genevieve Maenhaut-Michel, Johannes Geiselmann
J. Mol. Biol. October 14, 2005; 353: 186-195
Amos B Oppenheim, Oren Kobiler, Joel Stavans, Donald L Court, Sankar Adhya
Annu. Rev. Genet. 2005; 39: 409-429
H O Smith, M Levine
Virology February 1967; 31: 207-216
Michael P Nicoll, Joao T Proenca, Stacey Efstathiou
FEMS Microbiol. Rev. May 2012; 36: 684-705
Samantha J McDonnel, Ellen E Sparger, Brian G Murphy
Retrovirology 2013; 10: 69
Robert F Siliciano, Warner C Greene
Cold Spring Harb Perspect Med September 2011; 1: a007096
Michael D Lairmore, Rajaneesh Anupam, Nadine Bowden, Robyn Haines, Rashade A H Haynes 2nd, Lee Ratner, Patrick L Green
Viruses July 2011; 3: 1131-1165
Risaku Fukumoto
Cancer Sci. August 2013; 104: 983-988
G. Hahn, R. Jores, E. S. Mocarski
Proc. Natl. Acad. Sci. U.S.A. March 31, 1998; 95: 3937-3942
Jesse H. Arbuckle, Maria M. Medveczky, Janos Luka, Stephen H. Hadley, Andrea Luegmayr, Dharam Ablashi, Troy C. Lund, Jakub Tolar, Kenny De Meirleir, Jose G. Montoya, Anthony L. Komaroff, Peter F. Ambros, Peter G. Medveczky
Proc. Natl. Acad. Sci. U.S.A. March 23, 2010; 107: 5563-5568
K. Kondo, T. Kondo, T. Okuno, M. Takahashi, K. Yamanishi
J. Gen. Virol. June 1991; 72:1401-1408
Fumi Miyake, Tetsushi Yoshikawa, He Sun, Akira Kakimi, Masahiro Ohashi, Shiho Akimoto, Yukihiro Nishiyama, Yoshizo Asano
J. Med. Virol. January 2006; 78: 112-116
Israel Steiner, Peter G. E. Kennedy, Andrew R. Pachner
Lancet Neurol November 2007; 6: 1015-1028
Matching UniProtKB/Swiss-Prot entries
(all links/actions below point to uniprot.org website)47 entries grouped by protein
1 entry
Replication and transcription activator (Rta) (Immediate-early protein Rta) (Protein R)
2 entries
Replication and transcription activator (Rta) (Immediate-early protein Rta) (Protein R)
1 entry
Lytic switch protein BZLF1 (EB1) (Protein Z) (Trans-activator protein BZLF1) (Zta) (bZIP transcription factor ZEBRA)
3 entries
Epstein-Barr nuclear antigen 1 (EBNA-1) (EBV nuclear antigen 1) (EC 3.1.21.-)
3 entries
Epstein-Barr nuclear antigen 6 (EBNA-6) (EBV nuclear antigen 6) (Epstein-Barr nuclear antigen 3C) (EBNA-3C) (EBV nuclear antigen 3C) (Epstein-Barr nuclear antigen 4B) (EBNA-4B) (EBV nuclear antigen 4B)
2 entries
E3 ubiquitin-protein ligase ICP0 (EC 2.3.2.27) (Alpha-0 protein) (Immediate-early protein IE110) (RING-type E3 ubiquitin transferase ICP0) (Trans-acting transcriptional protein ICP0) (VMW110)
1 entry
Protein ORF49
1 entry
Regulatory protein cro
1 entry
Repressor protein c (Repc) (CI) (Gene product 1) (gp1) (Mu repressor) (MuR)
14 entries
Ribonucleoside-diphosphate reductase large subunit (R1) (EC 1.17.4.1) (Ribonucleotide reductase large subunit)
15 entries
Ribonucleoside-diphosphate reductase small subunit (EC 1.17.4.1) (Ribonucleotide reductase small subunit)
1 entry
Repressor protein cI
1 entry
Transcriptional activator II
1 entry